{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:51:43Z","timestamp":1777870303468,"version":"3.51.4"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-022-01530-7","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T04:03:58Z","timestamp":1673409838000},"page":"407-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term outcomes of add-on direct renin inhibition in igA nephropathy: a propensity score-matched cohort study"],"prefix":"10.1093","volume":"36","author":[{"given":"Davina N. W.","family":"Lie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kam Wa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander H. N.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony T. P.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary C. W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kar Neng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-1941","authenticated-orcid":false,"given":"Sydney Chi-Wai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"issue":"5","key":"1530_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","volume":"38","author":"FP Schena","year":"2018","unstructured":"Schena FP, Nistor I (2018) Epidemiology of IgA nephropathy: a global perspective. Semin Nephrol 38(5):435\u2013442","journal-title":"Semin Nephrol"},{"issue":"10225","key":"1530_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B et al (2020) Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395(10225):709\u2013733","journal-title":"Lancet"},{"issue":"3","key":"1530_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2215\/CJN.00890306","volume":"1","author":"PL Kimmel","year":"2006","unstructured":"Kimmel PL, Peterson RA (2006) Depression in patients with end-stage renal disease treated with dialysis: has the time to treat arrived? Clin J Am Soc Nephrol 1(3):349\u2013352","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1530_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/ajkd.2001.26824","volume":"38","author":"F Valderr\u00e1bano","year":"2001","unstructured":"Valderr\u00e1bano F, Jofre R, L\u00f3pez-G\u00f3mez JM (2001) Quality of life in end-stage renal disease patients. Am J Kidney Dis 38(3):443\u2013464","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1530_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000189102","volume":"73","author":"G Morduchowicz","year":"1996","unstructured":"Morduchowicz G, Boner G (1996) Hospitalizations in dialysis end-stage renal failure patients. Nephron 73(3):413\u2013416","journal-title":"Nephron"},{"issue":"5","key":"1530_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrneph.2012.58","volume":"8","author":"KN Lai","year":"2012","unstructured":"Lai KN (2012) Pathogenesis of IgA nephropathy. Nat Rev Nephrol 8(5):275\u2013283","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"1530_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1001\/jamainternmed.2019.0600","volume":"179","author":"SJ Barbour","year":"2019","unstructured":"Barbour SJ et al (2019) Evaluating a new international risk-prediction tool in IgA nephropathy. JAMA Intern Med 179(7):942\u2013952","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1530_CR8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.kint.2020.07.046","volume":"99","author":"FP Schena","year":"2021","unstructured":"Schena FP et al (2021) Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy. Kidney Int 99(5):1179\u20131188","journal-title":"Kidney Int"},{"issue":"4","key":"1530_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.kint.2018.04.004","volume":"94","author":"ZD B\u00e9k\u00e1ssy","year":"2018","unstructured":"B\u00e9k\u00e1ssy ZD et al (2018) Aliskiren inhibits renin-mediated complement activation. Kidney Int 94(4):689\u2013700","journal-title":"Kidney Int"},{"issue":"1","key":"1530_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/ckj\/sfz142","volume":"13","author":"MV Perez-Gomez","year":"2019","unstructured":"Perez-Gomez MV, Ortiz A (2019) Aliskiren and the dual complement inhibition concept. Clin Kidney J 13(1):35\u201338","journal-title":"Clin Kidney J"},{"issue":"2","key":"1530_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/ndt\/gfr349","volume":"27","author":"SCW Tang","year":"2011","unstructured":"Tang SCW et al (2011) Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study. Nephrol Dial Transplant 27(2):613\u2013618","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1530_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062736","volume":"8","author":"CC Szeto","year":"2013","unstructured":"Szeto CC et al (2013) The safety and short-term efficacy of aliskiren in the treatment of immunoglobulin a nephropathy\u2013a randomized cross-over study. PLoS\u00a0One 8(5):e62736","journal-title":"PLoS\u00a0One"},{"issue":"23","key":"1530_CR13","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","volume":"367","author":"HH Parving","year":"2012","unstructured":"Parving HH et al (2012) Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 367(23):2204\u20132213","journal-title":"N Engl J Med"},{"issue":"9","key":"1530_CR14","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/ndt\/gfaa085","volume":"36","author":"SCW Tang","year":"2021","unstructured":"Tang SCW et al (2021) Direct renin inhibition in non-diabetic chronic kidney disease (DRINK): a prospective randomized trial. Nephrol Dial Transplant 36(9):1648\u20131656","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1530_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","volume":"64","author":"AS Levey","year":"2014","unstructured":"Levey AS et al (2014) GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 64(6):821\u2013835","journal-title":"Am J Kidney Dis"},{"key":"1530_CR16","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1046\/j.1523-1755.2000.07420.x","volume":"57","author":"R Jofre","year":"2000","unstructured":"Jofre R, L\u00f3pez-G\u00f3mez JM, Valderr\u00e1bano F (2000) Quality of life for patient groups. Kidney Int 57:S121\u2013S130","journal-title":"Kidney Int"},{"issue":"1\u20133","key":"1530_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000452650","volume":"43","author":"S De Rosa","year":"2017","unstructured":"De Rosa S et al (2017) Management of chronic kidney disease patients in the intensive care unit: mixing acute and chronic illness. Blood Purif 43(1\u20133):151\u2013162","journal-title":"Blood Purif"},{"issue":"11","key":"1530_CR18","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/jama.2013.1954","volume":"309","author":"M Gheorghiade","year":"2013","unstructured":"Gheorghiade M et al (2013) Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA 309(11):1125\u20131135","journal-title":"JAMA"},{"issue":"1","key":"1530_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/j.ajkd.2006.10.014","volume":"49","author":"PA Sarafidis","year":"2007","unstructured":"Sarafidis PA, Khosla N, Bakris GL (2007) Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis 49(1):12\u201326","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1530_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ki.2009.499","volume":"77","author":"SC Tang","year":"2010","unstructured":"Tang SC et al (2010) Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int 77(6):543\u2013549","journal-title":"Kidney Int"},{"issue":"6","key":"1530_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2215\/CJN.10681014","volume":"10","author":"LF Fried","year":"2015","unstructured":"Fried LF, Lewis J (2015) Albuminuria is not an appropriate therapeutic target in patients with CKD: the con view. Clin J Am Soc Nephrol 10(6):1089\u20131093","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1530_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1053\/j.ajkd.2014.02.020","volume":"64","author":"LA Inker","year":"2014","unstructured":"Inker LA et al (2014) Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis. Am J Kidney Dis 64(1):74\u201385","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1530_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.nefro.2018.11.011","volume":"39","author":"L Belmar Vega","year":"2019","unstructured":"Belmar Vega L et al (2019) Epidemiology of hyperkalemia in chronic kidney disease. Nefrologia 39(3):277\u2013286","journal-title":"Nefrologia"},{"issue":"6","key":"1530_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.xkme.2020.09.003","volume":"2","author":"E Kanda","year":"2020","unstructured":"Kanda E et al (2020) Clinical and economic burden of hyperkalemia: a nationwide hospital-based cohort study in Japan. Kidney Med 2(6):742-752.e1","journal-title":"Kidney Med"},{"issue":"2","key":"1530_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/ndt\/gfz290","volume":"35","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL et al (2020) Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial. Nephrol Dial Transplant 35(2):274\u2013282","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-022-01530-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:52:24Z","timestamp":1777564344000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/36\/2\/407\/8303743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["1530"],"URL":"https:\/\/doi.org\/10.1007\/s40620-022-01530-7","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]},"assertion":[{"value":"25 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This project was approved by the joint Institutional Review Board and Ethics Committee of the Hong Kong Hospital Authority and the University of Hong Kong. This study is reported according to STROBE.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. No personal information was included.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}